Literature DB >> 15147973

Bisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alpha.

Tomoko Kubo1, Nobuhiro Maezawa, Mayuko Osada, Shigeo Katsumura, Yoshihiko Funae, Susumu Imaoka.   

Abstract

Bisphenol A (BpA), an endocrine-disrupting chemical, is known to be a xenoestrogen and to affect the reproductive functions of animals. Recent reports have documented BpA-induced developmental abnormalities in the neuronal systems of humans and animals, and these effects appear to be non-estrogenic. In this study, we found that BpA inhibited the hypoxic response of human hepatoma cells. The expression of hypoxic response genes such as the erythropoietin (EPO) gene is done via a hypoxia inducible factor 1 (HIF-1)-dependent signaling pathway. To investigate possible structural requirements for this inhibitory effect, several BpA analogs were synthesized and added to this system. The blocking of two phenol groups in BpA did not change the effect, but the inhibition completely disappeared by the removal of two central methyl groups in BpA (the resulting compound is designated BpF). BpA, but not BpF, promoted degradation of the HIF-1alpha protein, which is a component of HIF-1, followed by inhibition of EPO induction. An immunoprecipitation assay indicated that BpA dissociated heat shock protein 90 (Hsp90) from HIF-1alpha and destabilized HIF-1alpha protein. HIF-1alpha is usually degraded first by ubiquitination and then by the proteasome pathway. Cobalt ion inhibits ubiquitination of HIF-1alpha and stabilizes it. In the present study, BpA promoted HIF-1alpha degradation in the presence of cobalt and in the presence of proteasome inhibitor. These results suggest that BpA degraded HIF-1alpha via a currently unknown pathway, and that this phenomenon required two methyl groups in BpA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147973     DOI: 10.1016/j.bbrc.2004.04.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  HIF-1alpha: a valid therapeutic target for tumor therapy.

Authors:  Soon-Sun Hong; Hyunseung Lee; Kyu-Won Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

Review 2.  Bisphenol A and its effects on the systemic organs of children.

Authors:  Sarah Zulkifli; Amirah Abdul Rahman; Siti Hamimah Sheikh Abdul Kadir; Noor Shafina Mohd Nor
Journal:  Eur J Pediatr       Date:  2021-04-24       Impact factor: 3.183

3.  Chemical Exposure-Induced Developmental Neurotoxicity in Head-Regenerating Schmidtea mediterranea.

Authors:  Johnathan Morris; Elizabeth J Bealer; Ivan D S Souza; Lauren Repmann; Hannah Bonelli; Joseph F Stanzione Iii; Mary M Staehle
Journal:  Toxicol Sci       Date:  2022-01-24       Impact factor: 4.849

4.  Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2).

Authors:  Kazunobu Baba; Haruka Morimoto; Susumu Imaoka
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

Review 5.  Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.

Authors:  Tianchi Yu; Bo Tang; Xueying Sun
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

6.  Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.

Authors:  Tiangong Lu; Jianming Tang; Binita Shrestha; Blake R Heath; Li Hong; Yu L Lei; Mats Ljungman; Nouri Neamati
Journal:  Theranostics       Date:  2020-05-25       Impact factor: 11.556

Review 7.  The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.

Authors:  Song Peng; Jun Zhang; Xintao Tan; Yiqiang Huang; Jing Xu; Natalie Silk; Dianzheng Zhang; Qiuli Liu; Jun Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-24       Impact factor: 5.555

Review 8.  The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition.

Authors:  Michael A Serwetnyk; Brian S J Blagg
Journal:  Acta Pharm Sin B       Date:  2020-11-24       Impact factor: 11.413

Review 9.  Targeting energy metabolism to eliminate cancer cells.

Authors:  Shazwin Hani Shahruzaman; Sharida Fakurazi; Sandra Maniam
Journal:  Cancer Manag Res       Date:  2018-07-31       Impact factor: 3.989

Review 10.  Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability.

Authors:  Marina Pierrevelcin; Quentin Fuchs; Benoit Lhermitte; Melissa Messé; Eric Guérin; Noelle Weingertner; Sophie Martin; Isabelle Lelong-Rebel; Charlotte Nazon; Monique Dontenwill; Natacha Entz-Werlé
Journal:  Cells       Date:  2020-08-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.